The table presents a list of submission components, outlining a full application cycle from application to project launch.

The application step involves submission of the following components:

  • Project abstract (maximum 250 words)
  • Project summary (maximum one page)
    • Research overview
    • Overall structure of the study team
    • Study timeline
  • Background and significance (maximum two pages)
    • Project relevance to community health
    • Potential benefits of the proposed research
    • Importance of the knowledge gained
  • Specific aims and research procedures (maximum three pages)
    • Primary and secondary aims
    • Study design and research procedures
    • Study population characteristics (if applicable)
    • Project feasibility statement
  • Key personnel
    • Names and affiliation
    • Biosketch(es)
  • Leadership plan (maximum one page)
    • Roles, responsibilities, and working relationships of key collaborators
    • Value of community-researcher partnership
  • Description of next steps (maximum one page)
  • Applicant authorization and approval form
  • Project budget
  • Letter(s) of support (maximum five letters; optional, but highly recommended)

The post-award NCATS step involves submission of the following components (for human subject research only):

  • Project summary (maximum one page)
    • Research overview
    • Overall structure of the study team
    • Study timeline
  • Background and significance (maximum two pages)
    • Project relevance to community health
    • Potential benefits of the proposed research
    • Importance of the knowledge gained
  • Specific aims and research procedures (maximum three pages)
    • Primary and secondary aims
    • Study design and research procedures
    • Study population characteristics (if applicable)
    • Project feasibility statement
  • Key personnel
    • Names and affiliation
    • Biosketch(es)
  • Project budget
  • Certification of IRB approval or proof of exempt status determination
  • For clinical trials and greater than minimal risk human subject studies:
    • Human subjects training certificate(s)
    • Study protocol
    • Protection and monitoring plan
    • Protocol synopsis (for clinical trials only)